Karabulut, S. Et Al. 2016. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy. JOURNAL OF BUON , vol.21, no.4 , 895-902.

Karabulut, S., Afsar, C. U., KARABULUT, M., ALIS, H., Erturk, K., KARAMAN, Ş., ... KONES, O.(2016). Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy. JOURNAL OF BUON , vol.21, no.4, 895-902.

Karabulut, ÇİĞDEM Et Al. "Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy," JOURNAL OF BUON , vol.21, no.4, 895-902, 2016

Karabulut, ÇİĞDEM U. Et Al. "Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy." JOURNAL OF BUON , vol.21, no.4, pp.895-902, 2016

Karabulut, S. Et Al. (2016) . "Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy." JOURNAL OF BUON , vol.21, no.4, pp.895-902.

@article{article, author={ÇİĞDEM USUL AFŞAR Et Al. }, title={Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy}, journal={JOURNAL OF BUON}, year=2016, pages={895-902} }